AMIA, along with a coalition of over 80 medical and research organizations, wrote to Congressional leaders on June 10, 2025, expressing urgent concerns about the National Institutes of Health. The letter highlights three critical issues: scientists cannot access legally appropriated research funds despite excellent grant scores; NIH is being restructured […]
AMIA submitted comments to the CMS RFI: Unleashing Prosperity Through Deregulation of the Medicare Program recommending the elimination or significant streamlining of prior authorization (PA) requirements as the primary Medicare deregulation priority. We stand that PA creates substantial administrative burden, with physicians spending 2+ days weekly on approvals, while 80% […]
In response to the National AI R&D Strategic Plan RFI, AMIA calls for embedding healthcare priorities within AI research and development efforts. They advocate for ethical R&D practices grounded in transparency, safety, fairness, and equity. AMIA emphasizes the need for high-quality data, bias mitigation, and interdisciplinary collaboration to guide responsible […]
